Provided by Tiger Trade Technology Pte. Ltd.

Agree

71.23
-0.2600-0.36%
Post-market: 71.230.00000.00%19:52 EDT
Volume:1.41M
Turnover:100.64M
Market Cap:8.86B
PE:38.47
High:71.87
Open:71.87
Low:70.97
Close:71.49
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.02
T/O Rate:1.16%
Dividend:3.14
Dividend Rate:4.41%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.40
PE(LYR):40.24

Loading ...

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

ADC Therapeutics completes enrollment in Phase 1b Zynlonta trial

TIPRANKS
·
Jun 30

Henlius Starts First-in-Human Trial of Novel Dual-Target Cancer ADC HLX48

TIPRANKS
·
Jun 30

Lonza Boosts HPAPI and Payload-Linker Capacity to Capture ADC Growth

TIPRANKS
·
Jun 30

EMEA Morning Briefing: Futures Rise After U.S., Iran Agree to End Days of Fighting

Dow Jones
·
Jun 29

Oil Prices, Stock Futures Inch Higher as U.S. and Iran Reportedly Agree to Halt Attacks

Dow Jones
·
Jun 29

U.S. and Iran Agree to Stop Fight over the Strait of Hormuz

Dow Jones
·
Jun 29

My Partner and I Can't Agree on How to Track Our Money. Is There a System That Works for Two People?

Benzinga_recent_news
·
Jun 29

Analysts Offer Insights on Healthcare Companies: ADC Therapeutics (ADCT) and Lantheus (LNTH)

TIPRANKS
·
Jun 27

VERAXA Biotech (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

TIPRANKS
·
Jun 26

ADC Therapeutics Announces ZYNLONTA-Focused Strategic Reorganization

TIPRANKS
·
Jun 24

ADC Therapeutics Slashes Workforce in Reorganization Focused on Cancer Drug

Dow Jones
·
Jun 24

ADC Therapeutics to reduce workforce by 17% globally

TIPRANKS
·
Jun 24

VERAXA Biotech Expands R&D Hub in Heidelberg as Innovative BiTAC™-TCE and ADC Programs Advance Towards Clinical Development

GlobeNewswire
·
Jun 24

ITM Power and DB Systemtechnik Agree Green Hydrogen Partnership for Rail

TIPRANKS
·
Jun 24

Shilpa Biologicals Commissions Integrated ADC GMP Facility in India

TIPRANKS
·
Jun 24

Agomab, FDA Agree on Phase 2b Trial for Crohn's Disease Treatment

Dow Jones
·
Jun 24

Innovative CLDN18.2 ADC Drug from SBP GROUP Subsidiary Sees Marketing Application Accepted in China

Stock News
·
Jun 23

Trump Says Iran Will Agree to Weapons Inspections 'Long Into Future'

MT Newswires Live
·
Jun 23

Groundbreaking Dual-Antibody ADC Receives Market Approval, Signaling a Leap Forward for BIOKIN

Stock News
·
Jun 22